|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adeno
carcinoma
Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim
Cancer Res Treat.
2023;55(3):956-968. Published online February 27, 2023 DOI:
https://doi.org/10.4143/crt.2022.409
The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangio
carcinoma
: Its Prognostic Value Might Be Underestimated
So Jeong Yoon, Sunghae Park, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Jinsoo Rhu, Gyu-Seong Choi, Jong Man Kim, Jae-Won Joh, In Woong Han
Cancer Res Treat.
2023;55(3):948-955. Published online February 27, 2023 DOI:
https://doi.org/10.4143/crt.2023.290
Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular
Carcinoma
Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria
Ja Kyung Yoon, Dai Hoon Han, Sunyoung Lee, Jin-Young Choi, Gi Hong Choi, Do Young Kim, Myeong-Jin Kim
Cancer Res Treat.
2023;55(3):939-947. Published online February 10, 2023 DOI:
https://doi.org/10.4143/crt.2022.1645
Lung and Thoracic cancer
A Randomized Phase II Study of Irinotecan Plus Cisplatin with or without Simvastatin in Ever-Smokers with Extended Disease Small Cell Lung Cancer
Youngjoo Lee, Soo-Hyun Lee, Geon Kook Lee, Eun Jin Lim, Ji-Youn Han
Cancer Res Treat.
2023;55(3):885-893. Published online March 20, 2023 DOI:
https://doi.org/10.4143/crt.2023.283
Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer
Tae Hoon Lee, Joo-Hyun Chung, Hong-Gyun Wu, Suzy Kim, Joo Ho Lee, Bhumsuk Keam, Jin-Soo Kim, Ki Hwan Kim, Byoung Hyuck Kim, Hak Jae Kim
Cancer Res Treat.
2023;55(3):875-884. Published online February 24, 2023 DOI:
https://doi.org/10.4143/crt.2022.1583
EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced
EGFR
-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng
Cancer Res Treat.
2023;55(3):841-850. Published online February 13, 2023 DOI:
https://doi.org/10.4143/crt.2022.1438
Genitourinary cancer
Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell
Carcinoma
after Failure of One Prior Systemic Therapy
Sang Joon Shin, Jae Lyun Lee, Tae Gyun Kwon, Byoung Young Shim, Ho Seok Chung, Sang-Hee Kim, Se Hoon Park
Cancer Res Treat.
2023;55(2):643-651. Published online November 28, 2022 DOI:
https://doi.org/10.4143/crt.2022.883
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial
Carcinoma
of the Bladder
Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park
Cancer Res Treat.
2023;55(2):636-642. Published online October 6, 2022 DOI:
https://doi.org/10.4143/crt.2022.343
Cited By 1
Lung and Thoracic cancer
EGFR
Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
Hongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.
2023;55(2):498-505. Published online October 4, 2022 DOI:
https://doi.org/10.4143/crt.2022.388
Cited By 1
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
Yoon Jung Jang, Dong-gon Hyun, Wonjun Ji, Chang-Min Choi, Shinkyo Yoon, Dae Ho Lee, Sang-We Kim, Jae Cheol Lee
Cancer Res Treat.
2023;55(2):468-478. Published online November 28, 2022 DOI:
https://doi.org/10.4143/crt.2022.1342
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT
Carcinoma
Mi-Sook Lee, Sungbin An, Ji-Young Song, Minjung Sung, Kyungsoo Jung, Eun Sol Chang, Juyoung Choi, Doo-Yi Oh, Yoon Kyung Jeon, Hobin Yang, Chaithanya Lakshmi, Sehhoon Park, Joungho Han, Se-Hoon Lee, Yoon-La Choi
Cancer Res Treat.
2023;55(2):452-467. Published online October 14, 2022 DOI:
https://doi.org/10.4143/crt.2022.910
Gynecologic cancer
Effect of
BRCA1/2
Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.
2023;55(1):245-257. Published online July 19, 2022 DOI:
https://doi.org/10.4143/crt.2022.232
Genitourinary cancer
PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell
Carcinoma
Se Un Jeong, Hee Sang Hwang, Ja-Min Park, Sun Young Yoon, Su-Jin Shin, Heounjeong Go, Jae-Lyun Lee, Gowun Jeong, Yong Mee Cho
Cancer Res Treat.
2023;55(1):231-244. Published online March 2, 2022 DOI:
https://doi.org/10.4143/crt.2021.1526
Lung and Thoracic cancer
The Role of Adjuvant Therapy Following Surgical Resection of Small Cell Lung Cancer: A Multi-Center Study
Seong Yong Park, Samina Park, Geun Dong Lee, Hong Kwan Kim, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Tae Hee Hong, Yong Soo Choi, Jhingook Kim, Jong Ho Cho, Young Mog Shim, Jae Ill Zo, Kwon Joong Na, In Kyu Park, Chang Hyun Kang, Young-Tae Kim, Byung Jo Park, Chang Young Lee, Jin Gu Lee, Dae Joon Kim, Hyo Chae Paik
Cancer Res Treat.
2023;55(1):94-102. Published online June 9, 2022 DOI:
https://doi.org/10.4143/crt.2022.290
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with
ALK
+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Byoung Chul Cho, Dong-Wan Kim, Ullas Batra, Keunchil Park, Sang-We Kim, Cheng-Ta Yang, Pei-Jye Voon, Virote Sriuranpong, K. Govind Babu, Khalid Amin, Yingbo Wang, Paramita Sen, Khemaies Slimane, Sarayut Geater
Cancer Res Treat.
2023;55(1):83-93. Published online March 25, 2022 DOI:
https://doi.org/10.4143/crt.2021.1571
Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
Byoung Hyuck Kim, Joo-Hyun Chung, Jaeman Son, Suzy Kim, Hong-Gyun Wu, Hak Jae Kim
Cancer Res Treat.
2023;55(1):73-82. Published online March 14, 2022 DOI:
https://doi.org/10.4143/crt.2021.1202
Gynecologic cancer
Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Cancer Res Treat.
2022;54(4):1219-1229. Published online November 17, 2021 DOI:
https://doi.org/10.4143/crt.2021.1010
Cited By 1
Gastrointestinal cancer
Role of Esophagectomy after Chemoradiation Therapy in Patients with Locally Advanced Squamous Cell
Carcinoma
: A Comparative Analysis Stratified by Clinical Response to Chemoradiation Therapy
Jesang Yu, Jong Hoon Kim, Sung-Bae Kim, Sook Ryun Park, Young-Hee Kim, Hyeong Ryul Kim, Hyun Joo Lee, Ho June Song, Kye Jin Song, Jeong Yun Jang, Yoon Young Jo, Ye Jin Yoo
Cancer Res Treat.
2022;54(4):1148-1156. Published online December 20, 2021 DOI:
https://doi.org/10.4143/crt.2021.885
Breast cancer
Lobular
Carcinoma
In Situ
during Preoperative Biopsy and the Rate of Upgrade
Jeea Lee, Ga Yoon Ku, Haemin Lee, Hyung Seok Park, Ja Seung Ku, Jee Ye Kim, Seho Park, Byeong-Woo Park
Cancer Res Treat.
2022;54(4):1074-1080. Published online December 21, 2021 DOI:
https://doi.org/10.4143/crt.2021.864
Cited By 2
Lung and Thoracic cancer
A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer
Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi
Cancer Res Treat.
2022;54(4):1005-1016. Published online December 3, 2021 DOI:
https://doi.org/10.4143/crt.2021.986
Cited By 3
The Value of the Illness-Death Model for Predicting Outcomes in Patients with Non–Small Cell Lung Cancer
Kum Ju Chae, Hyemi Choi, Won Gi Jeong, Jinheum Kim
Cancer Res Treat.
2022;54(4):996-1004. Published online November 19, 2021 DOI:
https://doi.org/10.4143/crt.2021.902
Cited By 1
Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion
Yeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, Sung-Min Chun, Chang-Min Choi
Cancer Res Treat.
2022;54(4):985-995. Published online January 17, 2022 DOI:
https://doi.org/10.4143/crt.2021.857
Cited By 1
The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non–Small Cell Lung Cancer
Noeul Kang, Ki Hwan Kim, Byeong-Ho Jeong, Kyungjong Lee, Hojoong Kim, O Jung Kwon, Myung-Ju Ahn, Jeonghee Cho, Ho Yun Lee, Sang-Won Um
Cancer Res Treat.
2022;54(3):817-826. Published online November 9, 2021 DOI:
https://doi.org/10.4143/crt.2021.822
Cited By 2
Usefulness of Pulmonary Rehabilitation in Non-Small Cell Lung Cancer Patients Based on Pulmonary Function Tests and Muscle Analysis Using Computed Tomography Images
Juwhan Choi, Zepa Yang, Jinhwan Lee, Jun Hee Lee, Hyun Koo Kim, Hwan Seok Yong, Sung Yong Lee
Cancer Res Treat.
2022;54(3):793-802. Published online October 20, 2021 DOI:
https://doi.org/10.4143/crt.2021.769
Cited By 4
Selection Strategies and Practical Application of
BRAF
V600E-Mutated Non–Small Cell Lung
Carcinoma
Inwoo Hwang, Yoon-La Choi, Hyunwoo Lee, Soohyun Hwang, Boram Lee, Hobin Yang, Chaithanya Chelakkot, Joungho Han
Cancer Res Treat.
2022;54(3):782-792. Published online November 23, 2021 DOI:
https://doi.org/10.4143/crt.2021.843
Cited By 3
Histologic Changes in Non–Small Cell Lung Cancer under Various Treatments: A Comparison of Histology and Mutation Status in Serial Samples
Chang Gok Woo, Seung-Myoung Son, Ho-Chang Lee, Hye Sook Han, Ki Hyeong Lee, Dohun Kim, Eung-Gook Kim, Ok-Jun Lee
Cancer Res Treat.
2022;54(3):737-743. Published online September 24, 2021 DOI:
https://doi.org/10.4143/crt.2021.773
Cited By 4
Head and Neck cancer
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Han-Sin Jeong, Man Ki Chung, Myung-Ju Ahn
Cancer Res Treat.
2022;54(3):719-727. Published online November 1, 2021 DOI:
https://doi.org/10.4143/crt.2021.1019
Cited By 3
Gastrointestinal cancer
Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell
Carcinoma
Treated with Immune Checkpoint Inhibitors
Jwa Hoon Kim, Bokyung Ahn, Seung-Mo Hong, Hwoon-Yong Jung, Do Hoon Kim, Kee Don Choi, Ji Yong Ahn, Jeong Hoon Lee, Hee Kyoung Na, Jong Hoon Kim, Yong-Hee Kim, Hyeong Ryul Kim, Hyun Joo Lee, Sung-Bae Kim, Sook Ryun Park
Cancer Res Treat.
2022;54(2):505-516. Published online June 23, 2021 DOI:
https://doi.org/10.4143/crt.2020.1198
Cited By 14
Lung and Thoracic cancer
Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat.
2022;54(2):458-468. Published online September 10, 2021 DOI:
https://doi.org/10.4143/crt.2021.425
Cited By 5
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced
EGFR
-Mutant Lung Adeno
carcinoma
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Chun-Shih Chin, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J.W. Chen, Gee-Chen Chang
Cancer Res Treat.
2022;54(2):434-444. Published online August 2, 2021 DOI:
https://doi.org/10.4143/crt.2021.671
Cited By 8
1
2
3
4
5
6
7
8
9
10
Journal Impact Factor 4.6